Gelteq is trading at $0.54, down 10.12%, as rising Treasury yields and inflation concerns weigh on growth-oriented equities.
- The biotechnology sector is also under pressure, with XBI down 2.04%, while major indexes are lower.
- No new Gelteq-specific announcement was identified for September 24, 2026, making macro and sector weakness the most likely explanation.
- The decline is live during the regular session; volume data is unavailable.